Extranodal Nk T-cell Lymphoma Nasal Type
📧 Sign up to get email alerts when something new happens for Extranodal Nk T-cell Lymphoma Nasal Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction [Phase 1]
This Phase 1 trial evaluated bortezomib in patients with advanced cancer and kidney dysfunction. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating PXD101 in combination with 17-N-allylamino-17-demethoxygeldanamycin for metastatic or unresectable solid tumors o…
-
CLINICAL_TRIALS research · 2013-03-05Clinical Trial Update: Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma [Phase 2]
A Phase 2 study evaluating radiotherapy followed by adjuvant chemotherapy for Extranodal NK/T-cell lymphoma, nasal type.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma [Phase 2]
A Phase 2 trial evaluating radiotherapy alone versus concurrent chemoradiation for low-risk Extranodal NK/T-cell Lymphoma, Nasal Type, was t…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of gossypol, paclitaxel, and carboplatin in patients with metastatic or unresectable solid tumors, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma [Phase 2]
Phase 2 study evaluating a new combination regimen of L-asparaginase, dexamethasone, ifosfamide, cisplatin, and etoposide for extranodal NK/…
-
CLINICAL_TRIALS trial_result · 2009-10-21Clinical Trial Update: Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma [Phase 2]
Phase 2 trial of chemoradiation followed by the VIPD regimen for extranodal NK/T-cell lymphoma, nasal type, has completed.